Picture of Kolinpharma SpA logo

KIP — Kolinpharma SpA News Story

0.000.00%
it flag iconLast trade - 00:00
HealthcareBalancedMicro Cap

Brief: KOLINPHARMA H1 Net Result Turns To Profit Of EUR 0.4 Mln, Sees 2024 Revenue Between EUR 18-20 Mln

Sept 29 (Reuters) - Kolinpharma SpA  KIP.MI :
    * REPORTED ON TUESDAY H1 NET PROFIT EUR 0.4 MLN VS LOSS EUR
0.1
MLN YEAR AGO
    * UPDATES 2021 ESTIMATES, SEES SALES IN RANGE OF EUR
10.5-11.5
MILLION, EBITDA MARGIN IN LINE WITH H1 RESULTS
    * APPROVES 2021-2024 BUSINESS PLAN
    * TARGETS 2024 REVENUE IN RANGE OF EUR 18-20 MLN 

    
 Further company coverage:  KIP.MI  

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on Kolinpharma SpA

See all news